Changing the Practice of Medicine
Popular
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Chan Y. Cheah, MBBS
- MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Aditya Bardia, MD, MPH, FASCO
- CME/CE Broadcast Replay
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
1.00 creditMaria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
CME/CE
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Erica L. Mayer, MD, MPH
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Clinical Practice
Alessandra Tedeschi, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- Oncology and Hematology
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Michael Dolinger, MD, MBA
David T. Rubin, MD
Florence Odufalu, MD
David T. Rubin, MD
Florence Odufalu, MD
David T. Rubin, MD
Programs
Aditya Bardia, MD, MPH, FASCO
- Oncology and Hematology
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
Michael Dolinger, MD, MBA
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Ugo Iroku, MD, MHS
Michael Dolinger, MD, MBA
David T. Rubin, MD